We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARX
226
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$7.87M 0.1%
435,000
+285,000
+190% +$3.38M
CF icon
227
CF Industries
CF
$19.2B
$7.8M 0.1%
143,200
-40,213
-22% -$1.94M
CFG icon
228
Citizens Financial Group
CFG
$30.4B
$7.75M 0.1%
201,071
+2,362
+1% +$95.3K
AMBA icon
229
Ambarella
AMBA
$2.99B
$7.72M 0.1%
199,705
+8,761
+5% +$339K
CA
230
DELISTED
CA, Inc.
CA
$7.7M 0.1%
174,438
+133,126
+322% +$5.74M
PM icon
231
Philip Morris
PM
$301B
$7.69M 0.1%
94,278
-150,200
-61% -$12.3M
VFC icon
232
VF Corp
VFC
$6.68B
$7.66M 0.1%
87,040
+43,449
+100% +$3.71M
MGNX icon
233
MacroGenics
MGNX
$235M
$7.65M 0.1%
356,600
+265,000
+289% +$5.65M
WB icon
234
Weibo
WB
$1.9B
$7.53M 0.1%
103,000
-135,600
-57% -$10.9M
ZION icon
235
Zions Bancorporation
ZION
$10.1B
$7.5M 0.1%
149,597
-33,174
-18% -$1.75M
MITL
236
DELISTED
Mitel Networks Corporation
MITL
$7.48M 0.1%
+678,470
New +$7.45M
EQT icon
237
EQT Corp
EQT
$33.2B
$7.47M 0.1%
310,166
+74,512
+32% +$2.06M
K
238
DELISTED
Kellanova
K
$7.46M 0.1%
113,393
-30,832
-21% -$2.08M
JEF icon
239
Jefferies Financial Group
JEF
$12.9B
$7.42M 0.1%
+377,291
New +$7.87M
COST icon
240
Costco
COST
$415B
$7.38M 0.1%
31,428
+70
+0.2% +$15.8K
TGT icon
241
Target
TGT
$62.1B
$7.35M 0.1%
83,325
-6,106
-7% -$508K
ITUB icon
242
Itaú Unibanco
ITUB
$91.3B
$7.32M 0.1%
1,373,934
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
$7.31M 0.1%
100,327
+10,110
+11% +$686K
USB icon
244
US Bancorp
USB
$99.6B
$7.29M 0.1%
138,106
-81,860
-37% -$4.34M
COL
245
DELISTED
Rockwell Collins
COL
$7.29M 0.1%
51,894
+29,089
+128% +$4.01M
RIGL icon
246
Rigel Pharmaceuticals
RIGL
$680M
$7.28M 0.1%
226,800
+69,800
+44% +$2.1M
CTMX icon
247
CytomX Therapeutics
CTMX
$705M
$7.26M 0.1%
392,727
+212,600
+118% +$4.84M
APC
248
DELISTED
Anadarko Petroleum
APC
$7.17M 0.1%
106,355
+7,459
+8% +$503K
XLRN
249
DELISTED
Acceleron Pharma
XLRN
$7.15M 0.1%
125,000
+28,000
+29% +$1.38M
MO icon
250
Altria Group
MO
$122B
$7.15M 0.1%
118,595
-156,081
-57% -$9.27M

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.